Molecular Identification of t(w5): Vps52 Promotes Pluripotential Cell Differentiation Through Cell-Cell Interactions by Sugimoto, Michihiko et al.
Cell Reports
ArticleMolecular Identification of tw5: Vps52
Promotes Pluripotential Cell Differentiation
through Cell–Cell Interactions
Michihiko Sugimoto,1 Masayo Kondo,1 Michiko Hirose,2 Misao Suzuki,4 Kazuyuki Mekada,3 Takaya Abe,5
Hiroshi Kiyonari,5 Atsuo Ogura,2 Nobuo Takagi,6 Karen Artzt,7 and Kuniya Abe1,*
1Technology and Development Team for Mammalian Cellular Dynamics
2Bioresource Engineering Division
3Experimental Animal Division
RIKEN BioResource Center, Tsukuba, Ibaraki 305-00074, Japan
4Institute of Resource Development and Analysis, Kumamoto University, Kumamoto 860-0811, Japan
5Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan
6Division of Bioscience, Graduate School of Environmental Earth Science, Hokkaido University, Sapporo 060-0808, Japan
7Insititute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712, USA
*Correspondence: abe@rtc.riken.jp
http://dx.doi.org/10.1016/j.celrep.2012.10.004SUMMARY
After implantation, pluripotent epiblasts are con-
verted to embryonic ectoderm through cell–cell inter-
actions that significantly change the transcriptional
and epigenetic networks. An entrée to understanding
this vital developmental transition is the tw5 mutation
of the mouse t complex. This mutation produces
highly specific defects in the embryonic ectoderm
before gastrulation, leading to death of the embry-
onic ectoderm. Using a positional cloning approach,
we have now identified the mutated gene, complet-
ing a decades-long search. The gene, vacuolar
protein sorting 52 (Vps52), is a mouse homolog of
yeast VPS52 that is involved in the retrograde traf-
ficking of endosomes. Our data suggest that Vps52
acts in extraembryonic tissues to support the growth
and differentiation of embryonic ectoderm via cell–
cell interactions. It is also required in the formation
of embryonic structures at a later stage of develop-
ment, revealing hitherto unknown functions of Vps52
in the development of a multicellular organism.
INTRODUCTION
During an early phase of mammalian development, develop-
mental pluripotency is maintained by a particular cell lineage.
The blastocyst contains a clump of cells called the inner cell
mass (ICM), surrounded by trophectoderm. The ICM consists
of pluripotent cells, the epiblasts, that will contribute to the
embryo proper, and primitive endodermal cells that will give
rise to the extraembryonic endoderm. Remarkably, embryonic
stem cells (ESCs) can be derived from the ICM. After uterine
implantation, the blastocyst becomes the egg cylinder, which
consists of an ectoplacental cone, extraembryonic ectoderm,Cell Revisceral endoderm (VE), and embryonic ectoderm. In the egg
cylinder, pluripotent epiblasts are converted to embryonic ecto-
derm, a columnar epithelial layer surrounding a proamniotic
cavity. This morphogenetic conversion (also known as cavita-
tion) begins at about embryonic day 5.0 (E5.0), 1 day after
implantation (Coucouvanis and Martin, 1995). Both epiblasts
and embryonic ectoderm are pluripotent embryonic cells, but
pluripotent cells in the blastocyst and in egg-cylinder-stage
embryos display distinctly different developmental characteris-
tics. Therefore, here we define embryonic ectoderm as the
columnar epithelial cells formed after cavitation, and epiblasts
as their precursors that existed before cavitation. These two
cell types differ morphologically and functionally: epiblasts can
be transmitted to the next generation via germline chimeras,
whereas embryonic ectoderm cannot contribute to chimeras
(Rossant et al., 1978). The two cell types also show qualitatively
distinct epigenetic states, as exemplified by differences in their
genome-wide DNA methylation patterns (i.e., low in epiblasts
and higher in embryonic ectoderm; Borgel et al., 2010). Random
X chromosome inactivation in female mammals is not initiated
in the epiblast, but begins and is maintained stably in the embry-
onic ectoderm. Mouse ESCs and epiblasts within the ICM
represent a ground, or naı̈ve, state of pluripotency, whereas
embryonic ectoderm and EpiSCs, stem cell lines derived from
embryonic ectoderm (Brons et al., 2007; Tesar et al., 2007) corre-
spond to a more restricted, or primed, pluripotent state, and
these characteristics appear to be largely determined by growth
factors in the environment (Ng and Surani, 2011).
Epiblast-embryonic ectoderm conversion is associated with
significant changes in transcriptional and epigenetic networks,
and cell–cell interactions between the pluripotent cells and the
surrounding cells must play important roles in this transition.
However, it is largely unknown which factors or genes are impor-
tant for postimplantation changes. Mutants that display specific
defects in the relevant processes provide an unbiased entry
point for analyses. The tw5mutation, which occurs in the t haplo-
type, shows highly specific defects in the embryonic ectoderm ofports 2, 1363–1374, November 29, 2012 ª2012 The Authors 1363
Figure 1. Growth Defects in the Embryonic
Ectoderm of tw5/tw5 Embryos
(A–D) Gross morphology (A and B) and histological
sections (C and D) of tw5/+ (A and C) and tw5/tw5
embryos (B and D) at E6.5.
(E and F) Immunofluorescent images in tw5/+ (E)
and tw5/tw5 embryos (F) indicate well-developed
GATA4-positive VE (green) and a severe defect in
OCT3/4-positive embryonic ectoderm (magenta) in
the mutant. EPC, ectoplacental cone; Exe, extra-
embryonic ectoderm; Emb, embryonic ectoderm.
Scale bars, 100 mm (A, C, and E) and 50 mm (F). VE,
visceral endoderm. See also Figures S1 and S2.pregastrulating embryos, resulting in embryonic death at
approximately E6.5.
The t complex is a genetic region that spans 20 cM corre-
sponding to the proximal half of chromosome 17. The t haplo-
type is a naturally occurring variant form of the t-complex region
that harbors four nonoverlapping inversions that cause cross-
over suppression between t haplotype and wild-type (WT) chro-
mosomes. Thus, the t haplotype appears to behave genetically
as if it were a single locus (Barlow, 1992; Silver, 1993; Lyon,
2005), but crossovers are observed at normal rates between
two different, complementing t haplotypes (Silver and Artzt,
1981). Most mice with t haplotypes carry distinct recessive lethal
mutations that critically affect important steps in embryogenesis
and have been used to clarify certain features of early develop-
ment (Bennett, 1975). In fact, developmental mutations located
in the t complex are of great interest. The T (Brachyury) gene
has proved to be a key player in the development of mesoderm
in vertebrates (Herrmann et al., 1990), and the gene responsible
for the T-associated maternal effect (Tme) turned out to be Igf2r,
the first imprinted gene cloned in themouse (Barlow et al., 1991).
However, the causative genes identified in the t complex thus far
are of mutations occurring on WT chromosomes. Cloning the
recessive t-lethals in t haplotypes has been a huge technical
challenge. Because t haplotypes do not recombine with WT
chromosomes, the abundant genetic reagents and resources
that have been developed for analysis of WT chromosomes
cannot be applied. A scarcity of polymorphic markers between
complementing t haplotypes makes the genetic analysis of
t-lethals even more cumbersome (Frischauf, 1985), and none
of the recessive t-lethals that occur in the t haplotypes have1364 Cell Reports 2, 1363–1374, November 29, 2012 ª2012 The Authorsbeen identified molecularly to date. A
previous genetic study narrowed down
the tw5 critical region to 750 kb (Abe
et al., 2004a). In this work, we used
a series of five overlapping bacterial artifi-
cial chromosome (BAC) clones to func-
tionally rescue tw5 mutant embryos. We
then identified a candidate gene, vacuolar
protein sorting 52 (Vps52), and confirmed
its authenticity.
Vps52 is the mouse homolog of yeast
VPS52 that is involved in the retrograde
trafficking of endosomes (Bonifacino andRojas, 2006). Its function in the development of multicellular
organisms has been totally unknown. Our data strongly suggest
that via cell–cell interactions, Vps52 acts in extraembryonic
tissues, most likely in the VE, to support the developmental tran-
sition from epiblasts to embryonic ectoderm and growth, and is
also required in the embryonic ectoderm lineage for embryonic
vasculogenesis at a later stage of development.
RESULTS
The tw5-Lethal Mutation Affects the Growth and
Differentiation of Pluripotential Embryonic Cells
It is known that tw5 is a recessive mutation that causes death at
approximately E6.5 (Bennett and Dunn, 1958). As shown in
Figures 1A and 1C, WT E6.5 embryos consisted of embryonic
ectoderm, VE, extraembryonic ectoderm, and an ectoplacental
cone. By contrast, at the same stage, the tw5/tw5 embryos
were significantly smaller than the WT embryos (Figure 1B).
Histological analysis revealed that the epithelial layer of embry-
onic ectoderm was not formed at all in the tw5/tw5 embryos,
whereas the extraembryonic tissues were relatively well devel-
oped (Figures 1C, 1D, and S1A–S1D). Immunofluorescence
analysis with antibodies to OCT3/4, a marker for epiblast and
embryonic ectoderm, and toGATA4, a VEmarker, demonstrated
that growth of the embryonic ectoderm was severely affected,
whereas GATA4-positive VE was formed normally in tw5/tw5
embryos (Figures 1E, 1F, and S1E–S1G).
A bromodeoxyuridine (BrdU) incorporation assay also indi-
cated that cells in the extraembryonic tissues were actively
dividing in both WT and tw5/tw5 embryos, but the rate of cell
division was very low in the embryonic ectoderm of the mutants
comparedwith theWT (Figure S2). These results indicate that the
recessive lethal mutation in the tw5 haplotype affected the growth
and/or differentiation of cells of the epiblast lineage before the
initiation of gastrulation. Interestingly, the lethal effect was highly
specific spatially, in that cavitation in the extraembryonic portion
proceeded almost normally, whereas there seemed to be no
evidence of cavitation in the embryonic part of the mutant
embryos.
Positional Cloning of the Gene Responsible
for the tw5 Mutation
To identify the gene responsible for tw5, we used a positional
cloning approach. The 750-kb critical region for the mutation
(Vernet et al., 1998; Abe et al., 2004a) contains at least 42 tran-
scription units according to the current genome databases.
Genetic analysis of t haplotypes is technically difficult because
of the scarcity of markers that distinguish different t haplotypes.
Thus, it would be a cumbersome task to further narrow down the
critical region by conventional genetic mapping. Therefore, we
decided to identify tw5 by functional complementation through
BAC transgenesis. We injected BAC clones derived from the
MSM/Ms mouse (Abe et al., 2004b), an inbred strain derived
from the Japanese wild mouse, Mus musculus molossinus, into
fertilized eggs of C57BL/6 (B6) mice. Detection and measure-
ment of the copy number and messenger RNA (mRNA) expres-
sion level of the BAC transgene (Tomida et al., 2009) were facil-
itated by single nucleotide polymorphisms (SNPs) that were
frequently found between MSM/Ms and B6. As shown in Fig-
ure 2A, the 750-kb region was covered by five overlapping
BAC clones. Eleven transgenic lines were established using
those five BACs. The copy numbers of the integrated BAC trans-
gene and the level of mRNAs transcribed from the BAC trans-
gene in each strain were estimated by restriction fragment length
polymorphism genotyping of PCR products (data not shown).
The copy numbers of the integrated transgene varied from strain
to strain, ranging from one to >30. For example, the copy number
in the BAC5 line16 is one or two. Transcripts from the BAC trans-
genes were detected in all cases except for one line, which was
omitted from the subsequent analysis. We also confirmed by
DNA fluorescence in situ hybridization (FISH) that each BAC
transgene was integrated into a single chromosomal site other
than chromosome 17. For example, in BAC5 line 16, the trans-
gene was integrated into the chromosome 1C region (Figures
S3A and S3B). One or two lines of transgenic mice that carried
each of the BAC constructs showing high transgene expression
were selected and crossed with tw5 heterozygotes to make tw5/+
strains carrying each BAC transgene. These were then used for
functional complementation assays. After typing 497 pups, we
finally ascertained that only the BAC5 transgene could rescue
early embryonic lethality. Eleven pups with the tw5/tw5;BAC5
genotype were found among 159 offspring from the relevant
cross (Table 1; Figure 2B), whereas no tw5/tw5 homozygotes
were born. Subsequent analyses of the rescued fetuses and indi-
vidual pups suggested that the transgenic rescue was incom-
plete, because postnatal growth of the pups was affected and
some of the tw5/tw5;BAC5 fetuses showed slight developmental
retardation (Figures S3C–S3F). However, the functional rescueCell Reof embryonic lethality by the BAC5was highly specific and repro-
ducible, demonstrating strongly that the 177-kb BAC genomic
fragment should contain the responsible gene.
BAC5 is located in one of the most gene-rich regions in the
mouse genome (Abe et al., 1988) and carries at least 16 tran-
scription units. To identify the responsible gene within this
region, we cut the BAC5 insert into three pieces and repeated
the rescue experiment. We found that only the 54-kb PacI-RsrII
fragment could rescue fetuses from embryonic lethality (Fig-
ure 2A; Table 1). Finally, the 20-kb PsiI fragment derived from
the 54-kb fragment successfully complemented the lethal
phenotype (Figure 2A; Table 1). These results indicate that the
responsible gene should be in this 20-kb fragment, which
contains only one complete gene (Vps52), and just the 50 part
of the ribosomal protein s18 (Rps18) gene.
In yeast, the VPS52 gene is known to be involved in the retro-
grade transport of endosomes and to be a component of the
Golgi-associated retrograde protein (GARP) complex (Conibear
and Stevens, 2000). Up to now, however, the biological functions
of Vps52 in mouse development had not been studied.
The tw5 Haplotype Has a Frameshift Mutation in Exon 2
of Vps52
Given the results described above, it is highly likely that Vps52 is
mutated in the tw5 haplotype. Therefore, we sequenced the
Vps52 gene using cosmid clones isolated from the tw5 haplotype
genomic library (Uehara et al., 1987). In exon 2 of Vps52 of the B6
strain, there is a stretch of nine consecutive G nucleotides.
However, two additional Gs were found in the stretch of the tw5
haplotype (Figures 2C, 2D, and S4), resulting in a frameshift
mutation that generates a premature termination codon.
Because the t haplotype is highly diverged evolutionarily from
conventional laboratory strains, a number of SNPs and indels
can be found when two kinds of genome sequences are
compared; therefore, the frameshift mutation may represent
a t-haplotype-specific polymorphism that is unrelated to the
tw5 mutant phenotype. To clarify this point, we sequenced the
corresponding regions from another t haplotype, t12, and found
that this strain had nine Gs, as in the B6 strain (Figure S4).
tw5G Is a Viable Revertant of the tw5 Haplotype
that Corrects the Frameshift
tw5G is an apparent spontaneous revertant that occurred
25 years ago in amouse colony of tw5 tailless by tailless balanced
lethal cross (D. Bennett and K. Artzt, personal communication). It
showed up as a normal tailed female that, if she was a rare
recombinant, should have carried a recessive outside marker,
tufted. When she did not, the ‘‘new’’ t haplotype was rescued,
established, and named tw5G. This haplotype maintains all the
characteristics of a complete t haplotype. When the Vps52 allele
from tw5Gwas sequenced, it had 12G nucleotides in themutated
region, restoring the frameshift with one glycine insertion
(Figures 2C, 2D, and S4). These data again indicated that the
frameshift mutation found is not a generic t haplotype change
per se but is specific to the tw5 mutant.
As shown in Figure 2D, the predicted amino acid sequence of
the tw5 VPS52 is the same up to glycine 33, but is followed by 36
irrelevant amino acids and then a stop. Therefore, we predictedports 2, 1363–1374, November 29, 2012 ª2012 The Authors 1365
Figure 2. Identification of the Gene Responsible for the tw5-Lethal Mutation
(A) Schematic diagram of our transgenic rescue experiments. BAC5 Tg (blue line) and DNA fragments containing the full-length genomic region of Vps52 (brown
and red lines) were able to rescue the early embryonic lethality tw5.
(B) A litter of newborn mice from a tw5/+;BAC5 intercross. A rescued pup with the tw5/tw5;BAC5 genotype (arrow) is shown with its littermates.
(C) A frameshift mutation found in the tw5 haplotype. A 2 nucleotide (nt) insertion was detected at the start site ofVps52 exon 2 comparedwith the B6 control strain.
One more nucleotide insertion was detected in the revertant, tw5G haplotype, leading to restoration of the frameshift.
(D) Estimated amino acid sequences of the VPS52 N-terminal region. The 2 nt insertions observed in the tw5 haplotype will cause the frameshift mutation at amino
acid 34, and 3 nt insertions will result in reversion of the leading frame in the tw5G haplotype.
(E) Western blot analysis with anti-VPS52 and anti-GAPDH antibodies. VPS52 was not detected in tw5/tw5 ESCs, but was detected in both the rescued ESCs
(tw5/tw5;gVps52) and kidney of tw5G/tw5G mice.
(F) Genetic complementation test using Vps52 knockout and tw5 mice. Heterozygous embryos carrying the tw5/Vps52 knockout allele () showed a typical lethal
tw5/tw5 phenotype, indicating that Vps52 is the gene responsible for the tw5 mutation.
Scale bar, 200 mm. See also Figures S3–S5.
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Table 1. Results of Transgenic Rescue Experiments
Transgenic Mouse Line +/+ +/+;Tg tw5/+ tw5/+;Tg tw5/tw5 tw5/tw5;Tg Total
BAC1 line 8 5 8 17 35 0 0 65
BAC1 line 11 1 2 11 40 0 0 54
BAC2 line 9 8 6 7 23 0 0 44
BAC2 line 10 2 1 3 7 0 0 13
BAC3 line 4 5 16 4 35 0 0 60
BAC3 line 5 3 2 13 36 0 0 54
BAC4 0 6 13 29 0 0 48
BAC5 line 16 9 19 51 69 0 11 159
77 kb PvuI fragment line 1 1 1 9 8 0 0 19
77 kb PvuI fragment line 3 3 1 15 8 0 0 26
36 kb PvuI fragment line 1 2 2 10 22 0 0 36
36 kb PvuI fragment line 3 3 1 16 10 0 0 30
54 kb PacI-RsrII fragment 13 17 51 73 0 29 183
20 kb PsiI fragment line 1 1 2 11 22 0 7 42that the tw5 allele of Vps52 could not encode an authentic, full-
length protein. To confirm this, we generated a polyclonal anti-
body that recognizes amino acids 496–509 of mouse VPS52
(Figure 2E), and performed a western blot analysis on lysates
of B6 kidney, WT ESCs (EB3 cells), and tw5/tw5 null ESCs (Mag-
nuson et al., 1982). The antibody recognized a band of the ex-
pected size, 82 kDa, in the adult kidney of the B6 mice and in
the WT ESCs. However, the VPS52 band was not detected in
the tw5/tw5 ESCs (Figure 2E). The ESCs transduced with the
20-kb PsiI genomic fragment used for the transgenic rescue
experiment exhibited a band corresponding to VPS52, confirm-
ing that the tw5 homozygous ESCs had lost the ability tomake the
VPS52 protein, and that the 20-kb fragment restored the expres-
sion. Importantly, in the kidney of the revertant, tw5G homozy-
gous animal, the antibody clearly detected the VPS52 gene
product, suggesting a strong correlation between the pheno-
typic reversion and VPS52 production (Figure 2E).
Targeted Disruption of Vps52 Recapitulates the tw5
Mutant Phenotype
The results described above suggest strongly that the mutant
phenotype is most likely caused by the absence of the VPS52
gene product. To test this notion, we generated a targetedmuta-
tion of the Vps52 gene.Wemade a targeting vector in whichPgk-
Neo cassettes flanked by FRT sequences (white arrowhead in
Figure S5A) were positioned just upstream of exon 2. Two loxP
sites were also located in introns 1 and 2 so that Cre-mediated
recombination could remove exon 2 and/or the Pgk-Neo
cassettes. We designated the targeted allele as 2lox2frt (Neo).
We introduced the vector into ESCs and obtained three different
lines with the correctly targeted mutation. All three were trans-
mitted in the germline, and knockout mouse lines were success-
fully established (Figure S5B). Because these three mouse lines
showed essentially the same phenotypes, only the results of line
95 are shown. Mice carrying the targeted allele showed a reces-
sive tw5-like lethal phenotype, indicating that insertion of the
Pgk-Neo cassette into the intron 1 affected VPS52 expression,
leading to death. By mating the Vps52Neo/+ line with a CAG-Cell ReFLPe transgenic line ubiquitously expressing the Flippase (FLP)
enzyme (Kanki et al., 2006), we generated a 2lox1frt (flox) allele
(Figures S5A, S5C, and S5D).Mice homozygous for the flox allele
developed and grew normally, and showed normal fertility as
expected. When mated with a general deleter strain, CAG-Cre
(Matsumura et al., 2004), the Pgk-Neo cassette and exon 2
were removed efficiently from the Vps52Neo/+ mice, generating
a 1lox () allele (Figures S5A, S5C, and S5D). Although these
Vps52+/ heterozygotes showed a completely normal pheno-
type, Vps52/ homozygotes exhibited an early embryonic lethal
phenotype similar to that found in the tw5/tw5 embryos (data not
shown).We next crossed theVps52/+ heterozygotes with tw5 /+
mice to perform a genetic complementation test. All of the
compound heterozygotes (tw5/Vps52) isolated at E6.5 showed
defects in the embryonic ectoderm typical of tw5/tw5 embryos
(Figure 2F). Based on the results of the complementation test,
we conclude that Vps52 must be the gene responsible for the
tw5 mutation.
Vps52 Is Expressed Predominantly in the VE of Early
Postimplantation Embryos
According to publicly available microarray data from the UCSC
Genome Browser (http://genome.ucsc.edu/), Vps52 is ubiqui-
tously expressed in adult mice; however, the expression pattern
of Vps52 in embryos has not been reported. To understand its
functional role in embryogenesis, we carried out in situ hybridiza-
tion experiments. At E8.5, Vps52 appeared to be highly ex-
pressed in mesenchymal tissues, but it was barely detectable
in neuroepithelium of the neural tube (Figures 3A and 3B). Inter-
estingly, extraembryonic mesodermal cells comprising the yolk
sac also showed high expression. At E7.5, Vps52was expressed
in embryonic and extraembryonic mesoderm but was barely
detectable in embryonic ectoderm (Figures 3C and 3D). Because
the embryonic lethal phenotype is evident at E5.5–E6.5, we
examined Vps52 expression in embryos of these stages, but
failed to detect specific expression using the same probe and
experimental conditions, suggesting that it has lower expression
level at these stages (data not shown). Because the antibodyports 2, 1363–1374, November 29, 2012 ª2012 The Authors 1367
Figure 3. Expression of Vps52 during Early
Embryogenesis
(A–D) In situ hybridization analysis of E8.5
(A and B) and E7.5 embryos (C and D). Vps52
was highly expressed in mesodermal cells. NE,
neuroectoderm; YS, yolk sac; AmC, amniotic
cavity; EPC, ectoplacental cone; Am, amnion;
Ch, chorion; Emb, embryonic ectoderm; EmM,
embryonic mesoderm.
(E and F) Separation of three embryonic tissues for
tissue-specific RT-PCR analysis.Oct4-DPE-EGFP
(green) and Blimp1-mRFP (magenta) doubly posi-
tive E5.5 embryos shown in (E) were treated enzy-
matically and the embryonic tissues were sepa-
rated (F). EPC, ectoplacental cone; EPI, epiblast.
(G) RT-PCR analyses of Vps52, Vps53, and Vps54
genes, and tissue-specific markers. EPI, epiblast;
Exe, extraembryonic ectoderm.
Scale bars, 400 mm (B), 200 mm (D and B0), and
100 mm (D0). See also Figure S6.used for the western blot analysis was not suitable for immuno-
histochemistry, we tried to detect Vps52 transcripts in early
postimplantation embryos by tissue-specific RT-PCR analysis.
For this analysis, we used the transgenic mouse lines Oct4-
DPE-EGFP (Ohbo et al., 2003) and Blimp1-mRFP (Sugimoto
and Abe, 2007), in which embryonic ectoderm and VE of E5.5
embryos are marked specifically by enhanced green fluorescent
protein (EGFP) and monomeric red fluorescent protein (mRFP)
expression, respectively (Figures 3E and S6). After removing
the ectoplacental cone and enzymatic treatment, we physically
separated three embryonic tissues: mRFP-positive VE, EGFP-
positive embryonic ectoderm, and fluorescence-negative extra-
embryonic ectoderm (Figure 3F). We ensured the specificity of
tissue separation by examining the expression of the fluores-
cence reporters in these tissue fragments (Figures 3F and S6).
Using these tissue fragments, we generated complementary
DNAs (cDNAs) and analyzed the expression of a series of marker
genes by RT-PCR. The specific expression of various lineage
markers further validated the specificity of the cDNAs. Strong
expression of Vps52 was detected in VE, whereas Vps52
expression was barely detectable in embryonic ectoderm and
extraembryonic ectoderm (Figure 3G). Vps53, one of the other
components of the GARP complex, was also highly expressed
in VE, but much weaker expression was detected in embryonic
ectoderm and extraembryonic ectoderm, as in the case of
Vps52. However, Vps54, another component of the GARP
complex, was equally expressed in the three different embryonic
tissues. This may mean that the components of GARP (Vps52,1368 Cell Reports 2, 1363–1374, November 29, 2012 ª2012 The AuthorsVps53, and Vps54) are not necessarily
coexpressed in the same cells or tissues
of mouse embryos at this stage.
VPS52 Activity in Extraembryonic
Tissues Is Essential for
Development of the Embryo Proper
The results described above show clearly
that Vps52 was more highly expressed inVE than in embryonic ectoderm. This is counterintuitive because
the developmental defects of tw5 embryos are manifested in
the epiblasts/embryonic ectoderm but not in extraembryonic
tissues. To clarify this point, we carried out epiblast lineage-
specific disruption of the Vps52 gene by crossing Vps52flox/flox
female mice with Vps52+/–;Sox2-Cre transgenic male mice. It
was previously shown that the Sox2-Cre transgene is expressed
specifically in the epiblast lineage when it is paternally trans-
mitted (Hayashi et al., 2002, 2003).
Stage E9.5 embryos with a Vps52flox/ genotype developed
normally without showing any visible defects, as these are equiv-
alent to the tw5/+ genotype (Figure 4A). Remarkably, all of the
epiblast lineage-specific knockout embryos developed at least
until E9.5 (Figure 4B). Although the anterior half of the embryos
formed almost normally and a beating heart was observed, the
development of caudal structures was clearly retarded. These
morphological abnormalities were quite similar to those found
in the E9.5 tw5/tw5 embryos rescued by tetraploid complementa-
tion (Figures 4A, 4B, and S7; Sugimoto et al., 2003). At E8.5,
morphological differences were not discerned between the
embryo proper carrying either Vps52flox/ or Vps52flox/;Sox2-
Cre. However, close inspection of the yolk sacs revealed blood
congestion only in the Vps52flox/;Sox2-Cre embryos, indicating
a perturbation of vascular development (Figures 4C–4F). Immu-
nostaining with an endothelial marker, PECAM-1, demonstrated
unambiguously that coordinated vasculogenesis was compro-
mised in the epiblast lineage-specific null mutants for Vps52
(Figures 4G and 4H), probably causing the death of these
Figure 4. Epiblast Lineage-Specific Disruption of Vps52
(A and B) E9.5 embryos obtained from mating of Vps52flox/flox 3 Vps52+/;
Sox2-Cre mice. Compared with a normal littermate (A), the epiblast lineage-
specific Vps52 knockout embryos (B) showed characteristic defects in the
posterior region.
(C–H) E8.5 embryos obtained from mating of Vps52flox/flox 3 Vps52+/;Sox2-
Cre mice.
(C and D) Blood congestion in the yolk sac was observed in the epiblast-
specific knockout (D) but not in heterozygotes of littermates (C).
(E and F) Morphologies of the E8.5 embryo proper: Vps52flox/ (E) and
Vps52+/;Sox2-Cre (F).
(G and H) Abnormality in yolk sac vasculogenesis in the Vps52+/;Sox2-Cre
embryo. A part of the yolk sac was stained with anti-PECAM-1 antibody (white)
inVps52flox/ (G) and Vps52+/;Sox2-Cre (H). A normal vascular patterningwas
observed in the yolk sacs of normal littermates (G) but was severely disrupted
in the epiblast lineage-specific knockout embryos (H). YS, yolk sac.
Scale bars, 0.5 mm (A–F) and 100 mm (G and H). See also Figure S7.embryos. As described above, Vps52 is highly expressed in the
extraembryonic mesodermal component of the yolk sac. It is
thus likely that the defects in the yolk sac shown here were
caused by the absence of its expression, indicating that Vps52
has multiple functional roles in the development of early postim-
plantation and midgestation-stage embryos.
Vps52 Expression in VE Promotes Pluripotential Cell
Differentiation through Cell–Cell Interactions
Pluripotent ESC lines have been successfully isolated from
tw5/tw5 blastocysts (Magnuson et al., 1982). To establish a modelCell Resystem to study developmental defects of the tw5, we used this
line to make embryoid bodies (EBs) in vitro. The ESCs formed
EBs composed of undifferentiated cell aggregates surrounded
by a layer of GATA4-positive, primitive endoderm-like cells.
However, the tw5/tw5 EBs could not differentiate further and ap-
peared to be arrested at the same developmental stage (Figures
5A, 5C, and 5D), whereas the WT EBs initiated cavitation and
developed into cystic EBs. This suggests that a transition from
simple EBs to more developed EBs is somehow blocked in the
tw5/tw5 ESCs, reminiscent of the tw5/tw5 homozygotes. We trans-
duced the ESCs with the 20-kb PsiI fragment containing Vps52
(Figure 2A). Most of the EBs generated from the transduced
ESCs (tw5/tw5;gVps52) formed cystic structures in which pulsa-
tion of myocardial cells was frequently observed (Figures 5B,
5E, and 5F). This suggests that Vps52 expression might promote
tw5/tw5 ESCs from a developmentally inert state to a cellular state
poised for further differentiation. Restoration of developmental
potential was also achieved by a Vps52 cDNA construct. As
shown in Figure 5G, full-length cDNA driven by a native Vps52
promoter was introduced into the tw5/tw5 ESCs. The resultant
ESCs, tw5/tw5;cVps52, developed to cystic EBs efficiently.
A chimeric EB formation assay was carried out to test whether
VPS52 is involved in cell–cell interactions that promote the differ-
entiation of ESCs. The tw5/tw5 ESCs were first labeled with an
RFP, tdTomato (tw5/tw5;tdTomato; Figure 6A), and then mixed
with tw5/tw5;gVps52 ESCs (Figure 5B) at a ratio of 3:1. Then the
mixture was induced to form EBs. After 3 days of induction,
several EBs exhibited structures similar to postimplantation
embryos, with a cavity surrounded by an epithelial layer of
embryonic ectoderm (Figure 6B). The epithelial layer was
surrounded by a layer of endoderm-like cells (indicated by
arrows in Figure 6B). Remarkably, the outer layer was devoid
of red fluorescence, indicating that they were derived from the
tw5/tw5;gVps52 cells, whereas the internal ectoderm was mostly
tw5/tw5;tdTomato cells. These EBs eventually developed to
cystic EBs at day 7 of differentiation (Figure 6C). These results
suggest that cells expressing Vps52 contribute efficiently and
preferentially to VE, which in turn induces cavitation of the
tw5/tw5 ESCs. However, in contrast to studies using mouse
embryos, in which the involvement of extraembryonic ectoderm
cannot be ruled out, this ESC study suggests that the expression
of Vps52 only in the endoderm—probably VE—was sufficient to
induce differentiation of the tw5/tw5 ESCs, which would otherwise
be arrested as simple EBs. Thus, VPS52 is clearly a key factor in
the proper function of VE.Our data confirm that it triggers a series
of developmental events in early postimplantation embryos
through cell–cell interactions (Figure 7A).
DISCUSSION
Sixteen complementation groups that cause embryonic death at
specific developmental stages have been defined in t haplo-
types. Up to now, however, no gene that is responsible for any
classic t-lethal recessive mutation had been identified. Here,
we have unambiguously demonstrated that Vps52 is the gene
responsible for tw5, one of the classic, early-acting t-lethals.
More than 60 VPS genes have been identified in budding yeast
as being involved in the sorting of acid hydrolases to the vacuoleports 2, 1363–1374, November 29, 2012 ª2012 The Authors 1369
Figure 5. Phenotypic Rescue of tw5/tw5 ESCs with the Vps52
Transgene
(A and B) Complementation of the tw5/tw5 ESC defect with the Vps52 trans-
gene. tw5/tw5 ESCs can barely differentiate into cystic EBs (A), whereas
introduction of the Vps52 genomic fragment (tw5/tw5;gVps52) leads to efficient
differentiation of cystic EBs (B).
(C–F) Expression of the VE marker (GATA4) and the epiblast/embryonic
ectoderm marker (OCT3/4). In undifferentiated cells, GATA4 (magenta)
staining was essentially negative for undifferentiated tw5/tw5 ESCs (C) and
tw5/tw5;gVps52 ESCs (E), whereas OCT3/4 (green) showed positive immuno-
staining for both cell lines. GATA4-positive VE appeared to form in the
aggregates of tw5/tw5 ESCs (D) and tw5/tw5;gVps52 ESCs (F).
(G) Rescue of the differentiation defect of tw5/tw5 EBs by introduction of Vps52
cDNA. In the rescue experiments ([A], [B], and Figure 2A), the 20-kb Vps52
genomic fragment was used. The same rescue effect was obtained by using
Vps52 cDNA alone driven by the endogenous Vps52 promoter.
Scale bars, 200 mm (A, B, and G), and 100 mm (C–F).
Figure 6. Chimeric EB Assay Reveals that Vps52 Expression in VE
Promoted the Differentiation of Embryonic Ectoderm via Cell–Cell
Interactions
(A) A tw5/tw5 ESC line constitutively expressing the RFP tdTomato (magenta).
(B) Chimeric EB formed after 3 days of differentiation (day 3 EB).
tw5/tw5;tdTomato ESCs (A) weremixedwith tw5/tw5;gVps52 ESCs (Figure 5B) at
a ratio of 3:1, and EB formation was observed. A cavity inside the EB is indi-
cated by a white arrow. VE-like cells (marked with black arrowheads) did not
express tdTomato, indicating that they had the tw5/tw5;gVps52 genotype. Inner
cells surrounded by the VE-like cells showed tdTomato expression and
appeared to form an epithelial layer of embryonic ectoderm (marked with
white arrowheads).
(C) The chimeric tw5/tw5;tdTomato 4 tw5/tw5;gVps52 EB was able to develop
to a fully expanded, cystic EB.
Scale bars, 200 mm.
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nents of the GARP complex that is required for retrograde trans-
port from early and late endosomes to the late Golgi in yeast cells
(Conibear and Stevens, 2000). The components of the complex
(VPS52, VPS53, and VPS54) have been found in organisms
ranging from yeasts to humans (Bonifacino and Rojas, 2006).
Recently, the mammalian ortholog of the fourth component,hors
Figure 7. Model for the Function of Vps52 in the Differentiation of
Pluripotent Cells
(A) VE cells (green) emerge from an aggregate of naive pluripotent cells and
form a layer of cells surrounding the pluripotent cells. This differentiation step
may not need the function of VPS52. However, VPS52 expression in the VE is
required for transition from the naive to the primed state.
(B) VPS52 is involved in nutrient uptake through VE.
(C) VPS52 is involved in cell signaling between embryonic visceral endoderm
(EmVE) cells and epiblast/embryonic ectoderm, leading to the growth and
differentiation of naive pluripotent cells. Exe, extraembryonic part of the egg
cylinder; Emb, embryonic part of the egg cylinder; ExVE, extraembryonic
visceral endoderm.Vps51, was identified as being Ang2/fat-free (Pérez-Victoria
et al., 2010). The primary role of the GARP complex is in the
reception of endosome-derived transport carriers at the trans-
Golgi network (Pérez-Victoria et al., 2008). However, the effect
of GARP-disrupting mutations on development extends to
a broad range of cellular functions (Bonifacino and Hierro, 2011).
It is known that in yeast cells, the loss of each component of
the GARP complex causes identical phenotypes with reduced
growth rates. In mice, the wobbler mutant, which exhibits motor
neuron degeneration as well as defects in spermatid formation,
harbors a missense mutation in the C-terminal region of Vps54
(Schmitt-John et al., 2005). The wobbler seems to be a hypo-
morph of Vps54, because homozygotes carrying a gene trap
null allele die between E11.5 and E12.5, presumably from cardio-
vascular malfunction (Schmitt-John et al., 2005). Mutations in
either Vps52 or Vps53, the other components of GARP, have
not been reported in mice. Our data show that Vps52 exhibits
cell type-specific and tissue-specific functions, and that Vps52
has multiple developmental roles during mammalian embryo-
genesis. Moreover, these phenotypes of Vps52 mutants are
quite different from those of Vps54 mutants, implying that
Vps52 and Vps54 play distinct roles in mammalian development
depending on the cell types in which they are expressed.
Finally, our embryonic tissue-specific RT-PCR analysis showed
that Vps52 was predominantly expressed only in the VE,
whereas Vps54 was expressed in all three tissues examined.
Thus, Vps52 and Vps54 may not act at the same time in the
GARP complex at this developmental stage.Cell ReThe VE is an extraembryonic cell layer that performs critical
functions during embryogenesis (Bielinska et al., 1999). The
traditional role attributed to the VE involves nutrient uptake and
transport (Figure 7B), and in a previous study (Sugimoto et al.,
2003), tw5/tw5 embryos exhibited defects in endocytosis, with
a great reduction in uptake of horseradish peroxidase from the
incubation medium. Endocytic defects in the tw5/tw5 embryos
were apparent in the entire VE, but reduced cell proliferation
was seen specifically in the embryonic ectoderm/epiblast.
Therefore, low endocytic activity of the VE alone may not
account for the severe phenotype found in the embryonic
ectoderm.
Another possibility is that Vps52 is involved in the cell-
signaling function of VE, which is known to be a signaling center
required for development and patterning. During the cavitation
process, a reciprocal interaction between VE and epiblast
occurs, and involvement of BMP family members has been
proposed (Coucouvanis and Martin, 1995, 1999). We found
that Vps52-expressing tw5/tw5 ESCs formed the outer endo-
dermal layer of EBs to induce cavitation in otherwise cavita-
tion-defective tw5/tw5 ESCs. The mutant phenotypes of BMP-
related genes and transforming growth factor b (TGF-b)
superfamily genes resemble those of the tw5/Vps52 mutant in
several aspects (Bielinska et al., 1999). Furthermore, some of
those signaling factors showed restricted expression in the VE
associated with the embryonic ectoderm (EmVE), whereas rela-
tively few signaling factors displayed predominant expression in
extraembryonic VE (ExVE; Pfister et al., 2007). Collectively, these
results suggest that specific abnormalities in the embryonic part
of the tw5 mutant may be caused by defects in cell signaling
between the EmVE and embryonic ectoderm (Figure 7C). In
addition, analyses of other mutations in genes involved in retro-
grade transport, such as Hb58/Vps26 (Radice et al., 1991; Lee
et al., 1992) and Snx1/Snx2 (Schwarz et al., 2002; Griffin et al.,
2005), indicate that these genes also act in the VE-derived
tissues to support growth of the embryo proper. Even though
the tw5/Vps52 mutant exhibited a phenotypic resemblance to
known signaling mutants and/or the Vpsmutants, it still showed
more severe dysfunctions than did any of these mutants. Given
that endocytosis appears to be involved in the regulation of
most of the major developmental signaling pathways (Seto
et al., 2002; Sorkin and von Zastrow, 2009), it is tempting to
speculate that Vps52 acts as a key player in orchestrating
multiple signaling pathways that operate through the endocytic
machinery during early mammalian development.
We were able to reconstitute defects of tw5 null embryos using
the EB differentiation system (Figures 5 and 6), which should
enable progress in future biochemical/proteomic studies.
Expression of the Vps52 transgene rescued the differentiation
defect in tw5 null cells arrested in a naı̈ve pluripotent state. The
developmental transition from a naive to a primed state of plurip-
otent cells (or vice versa) is currently under intense investigation,
and this process is thought to be greatly influenced by signaling
factors (Ng and Surani, 2011). It should be possible to facilitate
this conversion process through the manipulation of Vps52
activity.
In summary, we have identified Vps52 as being responsible for
the tw5 mutation, and revealed development-specific functionsports 2, 1363–1374, November 29, 2012 ª2012 The Authors 1371
of this gene, which was formerly thought to be solely involved in
retrograde endocytic transport. This provides an entrée into the
functional study of Vps52 and related molecules, and the interre-
lations between endocytic machinery and developmental cell
signaling in mammalian embryos.
EXPERIMENTAL PROCEDURES
Mice
The mouse strains tw5 (RBRC01202), tw5G (RBRC01203), CAG-FLPe
(RBRC01834; Kanki et al., 2006), CAG-Cre (RBRC01828; Matsumura et al.,
2004), Blimp1-mRFP (RBRC01830; Sugimoto and Abe, 2007), and Oct4-
DPE-EGFP (RBRC00821; Ohbo et al., 2003) were provided by the Experi-
mental Animal Division of the RIKEN BioResource Center (BRC), through the
National Bio-Resource Project of MEXT, Japan. The tw5 mice were back-
crossed more than five times to C57BL/6 (B6) mice before they were used.
Sox2-Cre mice (stock no. 004783; Hayashi et al., 2002) were purchased
from the Jackson Laboratory (Bar Harbor, ME). All methods were approved
by the Institutional Animal Experiment Committee of RIKEN Tsukuba Institute.
Generation of Transgenic Mice for Genetic Rescue Experiments
Five BAC clones derived from the Japanese wild mouse strain MSM/Ms were
used to generate BAC transgenic mice (Abe et al., 2004b). The BAC clones are
available from the DNA Bank of RIKEN BRC (http://dna.brc.riken.jp/index.
html). Four subfragments of the BAC5 clone were also used to produce trans-
genic mice for subsequent rescue experiments. The mice generated in this
study have been deposited at the Experimental Animal Division, RIKEN BRC.
Generation of Conditional Knockout Mice
The Vps52 conditional knockout mice (accession number CDB0767K;
http://cdb.riken.jp/arg/mutant%20mice%20list.html) were generated essen-
tially as described previously (http://www.cdb.riken.jp/arg/Methods.html). A
targeting vector in which exon 2 of Vps52 is flanked by two loxP sites with
an FRT-Pgk-Neo-FRT sequence (Figure S5) was introduced into TT2 ESCs
(Yagi et al., 1993). Three independent candidate ESC lines were obtained,
and successful homologous recombination was confirmed by southern blot-
ting and PCR. All three lines contributed to germline chimeras, from which
Vps52+/Neomutant micewere obtained. The Vps52+/Neo andCAG-FLPe strains
were crossed to produce Vps52+/flox mice. The following primer set was used
for genotyping: (1) GGGATCACCTGGAATAGCTG, (2) GCCAGAGGCCACTTG
TGTAG, (3) GGGCTTGGATCTGAAACATC, and (4) GTGCCGGAGTAAGTGG
GTC (see Figure S5).
Immunofluorescence
Whole-mount immunofluorescence analysis was done as previously
described (Sugimoto and Abe, 2007). Fluorescent images were captured
with an LSM 510 META laser scanning microscope (Carl Zeiss, Oberkochen,
Germany). The primary antibodies were OCT3/4 (1:300, sc-8628; Santa Cruz
Biotechnology, Santa Cruz, CA), GATA4 (1:300, sc-9053; Santa Cruz Biotech-
nology), and PECAM1 (1:25, 550274; BD Biosciences, San Jose, CA). The
secondary antibodies were anti-goat immunoglobulin G (IgG) Alexa Fluor
594 (1:500, A11058; Life Technologies), anti-rabbit IgG Alexa Fluor 488
(1:500, A11058; Life Technologies), and anti-rat IgG Alexa Fluor 594 (1:500,
A11007; Life Technologies).
Western Blotting
A rabbit anti-VPS52 antibody was raised against a synthetic peptide corre-
sponding to VPS52 amino acids 496–509 (PQRLGGLDTRPHYI), followed by
affinity purification (Sigma-Aldrich Japan, Tokyo, Japan). Membrane was re-
acted with anti-VPS52 (1:1000) and anti-GAPDH (1:10,000, sc-32233; Santa
Cruz Biotechnology) antibodies. Signals were detected with an ECL Plus
Western Blotting Detection Kit (GE Healthcare, Little Chalfont, UK).
In Situ Hybridization
A 610-bp DNA fragment corresponding to nucleotide positions 1671–2280
was amplified by PCR from a full-length Vps52 cDNA clone (RIKEN FANTOM1372 Cell Reports 2, 1363–1374, November 29, 2012 ª2012 The Autclone ID: D130068D18; Carninci et al., 2005), and digoxigenin-labeled sense
and antisense RNA probes were prepared using the DIG RNA Labeling Mix
(Roche, Basel, Switzerland). Paraffin-wax-embedded sections (6 mm) of
E5.5–E8.5 mouse embryos were obtained from Genostaff Co. (Tokyo, Japan)
and hybridized at 60C for 16 hr. Specific signals were detected with a combi-
nation of alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche)
and NBT/BCIP (Sigma-Aldrich), followed by counterstaining with Kernechtrot
Stain Solution (Muto Pure Chemicals, Tokyo, Japan).
Embryonic-Tissue-Specific RT-PCR
E5.5 embryos were collected from matings of Oct4-DPE-EGFP and Blimp1-
mRFP mice. Separation of embryonic tissues was carried out as previously
described (Nagy et al., 2003) with minor modifications. To ensure the absence
of contamination of embryonic tissues, fluorescent microscopy was used to
check for reporter gene expression (see Figures 3 and S6). RNA was purified
with RNeasy Kits (QIAGEN, Venlo, The Netherlands) from pools of tissues iso-
lated from 16 embryos. Reverse transcription and cDNA amplification were
performed using aWT-Ovation Pico RNA Amplification System (NuGEN Tech-
nologies, San Carlos, CA). Primer sets and conditions of the PCR reactions are
shown in Table S1.
Plasmids
The Vps52 cDNA sequence amplified from full-length Vps52 cDNAwas cloned
into pENTR/D-TOPO (Life Technologies). To generate a pCMV-Vps52, the
insert was transferred into pcDNA3.1/nV5-DEST using Gateway technology
(Life Technologies). To construct pVps52-V5-Vps52, a 2.5-kb fragment con-
taining a promoter and the 50 untranslated region of Vps52 was amplified
from a BAC clone (RP23-213I16) and inserted into pCMV-Vps52, and the
CMV promoter was replaced using an In-Fusion HD Cloning Kit (Takara Bio,
Shiga, Japan). To generate pCAGGS-tdTomato, a BamHI/HindII fragment of
pREST-B tdTomato (Shaner et al., 2005) was cloned into a pCAGGS expres-
sion vector (Niwa et al., 1991) by blunt-end ligation using a DNA Blunting Kit
(Takara Bio).
ESC Culture
The tw5/tw5 ESC line (Magnuson et al., 1982) was maintained on mitomycin
C-treated mouse embryonic fibroblasts in minimum essential medium a
(MEMa; Sigma-Aldrich) supplemented with 14% knockout serum replacement
(KSR; Life Technologies), 1% fetal bovine serum (FBS; Life Technologies),
1,000 U/ml leukemia inhibitory factor (LIF), 0.1 mM 2-mercaptoethanol, 13
nonessential amino acids, 2 mM L-glutamine. EB3 ESCs (AES0139; Niwa
et al., 2002; Ogawa et al., 2004) were provided by the Cell Bank of the RIKEN
BioResource Center and maintained under feeder-free conditions according
to the supplied protocol. Transfection was done using Lipofectamine 2000
(Life Technologies).
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